Canfield Presents Webinar on Cardiotoxicity in Advanced Prostate Cancer Therapies
Join Steven Canfield, MD, for an insightful webinar on the cardiotoxicity of first-line therapies for advanced prostate cancer. This event will explore how common treatments, such as hormonal therapy and chemotherapy, may impact the cardiovascular system. Led by experts in…
Pew Pew! Laser Applications for Prostate Ablation
Steven Canfield, MD, Professor and Chair of the Division of Urology at McGovern Medical School at UTHealth Houston, provides a comprehensive evaluation of laser ablation’s role in prostate cancer management. In this 12-minute presentation, Dr. Canfield highlights patient selection criteria…
Canfield Presents at Focal Therapy Society Meeting in Washington, DC
At the recent Focal Therapy Society (FTS) meeting in Washington, DC, Steven E. Canfield, MD, professor and chief of the division of urology in the department of surgery, was invited to speak on the future of focal therapy, with an…
Real-world Utilization of Active Surveillance After GPS Testing for Localized Prostate Cancer
Steven Canfield, MD, of UTHealth Houston shares the results of his recent study looking at the real-world utilization of active surveillance among men with localized prostate cancer who were tested with the genomic prostate score assay. Dr. Canfield presented his…
At the Bedside: New focal therapies at UTHealth Houston make prostate cancer treatment easier on patients
One in eight men will be diagnosed with prostate cancer in his lifetime and 11 years ago, Morton McPhail, now 73, became one of them. Fortunately, time was on his side. The prostate gland, found only in men, produces seminal…